ACTRN12613000111774
Completed
N/A
A study for patients with advanced colorectal cancer, comparing midkine with carcino-embyonic antigen (CEA) and computed tomography (CT) scans to predict response to chemotherapy, and identify early cancer progression
Calvary Mater Newcastle Hospital0 sites33 target enrollmentJanuary 30, 2013
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Calvary Mater Newcastle Hospital
- Enrollment
- 33
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Ability to give informed consent
- •Metastatic or locally advanced colorectal cancer
- •Starting on a new course of chemotherapy for colorectal cancer
- •Adequate organ function to permit chemotherapy to be given
- •Life expectancy of more than 3 months
- •Measurable or non\-measurable lesions
- •Ability to comply with study procedures
Exclusion Criteria
- •Past history of malignancy, other than non\-melanoma skin cancers
- •Current active inflammatory, autoimmune or infective process
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
A study for people with advanced colorectal cancer who have been treated with a specific chemotherapy regimen (Bevacizumab, Oxaliplatin, and a Fluoropyrimidine) which was ineffective in stopping the spread of the colorectal cancer. Study participants will receive a different chemotherapy regimen (Irinotecan, Folinic Acid, and 5-Fluorouracil) and be randomly and unknowingly assigned to also receive the study drug (ramucirimab) or a non-active compound (placebo).Metastatic Colorectal CancerMedDRA version: 17.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2010-021037-32-DEEli Lilly and Company Limited, Indianapolis1,050
Completed
N/A
Vitamin C for Colorectal Cancer: A clinical window study to assess high dose vitamin C administration in colorectal cancer patientsColorectal cancerCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12615001277538Prof Margreet Vissers12
Active, Not Recruiting
N/A
Treatment Monitoring of Advanced Colorectal cancer with 18F-FDG PET/CTEUCTR2008-001499-55-FITurku PET Centre140
Recruiting
N/A
Prospective observational study of colorectal cancer examining diagnosis opportunity and risk factors, CRC-DR studyJPRN-UMIN000051316Kyoto Prefectural University of Medicine1,000
Not Yet Recruiting
N/A
Refractory advanced colorectal cancer in the treatment with integrated traditional Chinese and western medicine: a multi-center clinical studycolorectal cancerITMCTR2200006741onghua Hospital, Shanghai University of Traditional Chinese Medicine